Dementia: Treating patients and caregivers with complementary and alternative medicine - Results of a clinical expert conference using the world café method

Forschende Komplementarmedizin

Volumn 20, Issue 4, 2013, Pages 276-280

  Teut, Michael ^a   Bloedt, Susanne ^a   Baur, Roland ^a   Betsch, Frederik ^b   Elies, Michael ^c   Fruehwald, Maria ^b   Fuesgen, Ingo ^d   Kerckhoff, Annette ^b   Krüger, Eckard ^e   Schimpf, Dorothee ^b   Schnabel, Katharina ^a   Walach, Harald ^f   Warme, Britta ^c   Warning, Albercht ^g   Wilkens, Johannes ^e   Witt, Claudia M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Karl und Veronica Carstens Stiftung   (Germany)

^c Geriatrische Kliniken ^*

^d St Antonius gGmbH   (Germany)

^e Alexander Von Humboldt Klinik   (Germany)

^f EUROPEAN UNIVERSITY VIADRINA   (Germany)

^g Alanus Hochschule Alfter   (Germany)

Author keywords

Complementary and alternative medicine; Dementia; World Caf

Indexed keywords

AGED; ALTERNATIVE MEDICINE; ARTICLE; CAREGIVER; DEMENTIA; ECONOMICS; EXPERT WITNESS; FEMALE; GERMANY; HUMAN; MALE; ORGANIZATION; PERSONALIZED MEDICINE; QUESTIONNAIRE; STANDARD;

AGED; CAREGIVERS; COMPLEMENTARY THERAPIES; CONGRESSES AS TOPIC; DEMENTIA; EXPERT TESTIMONY; FEMALE; GERMANY; HUMANS; INDIVIDUALIZED MEDICINE; MALE; QUESTIONNAIRES;

EID: 84884269624     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000354595     Document Type: Article

References (13)

1. Weyerer S: Altersdemenz; in Robert Koch Institut (ed): Gesundheitsberichterstattung des Bundes, Themenheft 28. Berlin, 2005. www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/ GBEDownloadsT/altersdemenz.html (Zugriff vom 22.07.2013).
2. Potzsch O, Sommer B: Bevolkerung Deutschlands bis 2050 - Ergebnisse der 10. koordinierten Bevolkerungsvorausberechnung; in Statistisches Bundesamt (ed): Bevolkerung Deutschlands bis 2050. Wiesbaden, 2003.
3. Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C: The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 2012;16: 1-470.
4. Jessen F, Spottke A: Therapie von psychischen und Verhaltenssymptomen bei Demenz. Nervenarzt 2010;81: 815-822.
5. Hallauer JF, Schons M, Smala A, Berger K: Untersuchung von Krankheitskosten bei Patienten mit Alzheimer-Erkrankung. Gesundheitsokonomie und Qualitatsmanagement 2000;5: 73-79.
6. Mohamed S, Rosenheck R, Lyketsos CG, Schneider LS: Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriat Psychiatry 2010;18: 917-927.
7. Covinsky KE, Newcomer R, Fox P, Wood J, Sands L, Dane K, Yaffe K: Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med 2003; 18: 1006-1014.
8. Brown J, Isaacs D, and the World Cafe community of practice: The World Cafe Book: Shaping Our Futures through Conversations that Matter. San Francisco, Berrett-Koehler, 2005.
9. Perry E, Howes MJ: Medicinal plants and dementia therapy: herbal hopes for brain ageing? CNS Neurosci Ther 2011;17: 683-698.
10. Howes MJ, Perry E: The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 2011;28: 439-468.
11. Kennedy DO, Scholey AB: The psychopharmacology of European herbs with cognition enhancing properties. Curr Pharm Des 2006;12: 4613-4623.
12. Adams M, Gmunder F, Hamburger M: Plants traditionally used in age related brain disorders - a survey of ethnobotanical literature. J Ethnopharmacol 2007;113: 363-381.
13. Dementia Cochrane Group 2009: www.dementia. cochrane.org (Accessed 22.07.2013).